- Home
- ERAS vs ASM Comparison
ERAS vs ASM Comparison
Compare ERAS & ASM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ERAS | ASM |
|---|---|---|
| Founded | 2018 | 1968 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 920.7M |
| IPO Year | 2021 | 2005 |
Fundamental Metrics
Financial Performance| Metric | ERAS | ASM |
|---|---|---|
| Price | $15.99 | $6.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 3 |
| Target Price | ★ $11.38 | $8.18 |
| AVG Volume (30 Days) | 4.2M | ★ 5.1M |
| Earning Date | 03-12-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.23 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $58.00 |
| Revenue Next Year | N/A | $60.53 |
| P/E Ratio | ★ N/A | $67.93 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.01 | $1.37 |
| 52 Week High | $16.14 | $11.99 |
Technical Indicators
Market Signals| Indicator | ERAS | ASM |
|---|---|---|
| Relative Strength Index (RSI) | 64.22 | 36.81 |
| Support Level | $1.50 | $5.73 |
| Resistance Level | $16.14 | $6.32 |
| Average True Range (ATR) | 1.09 | 0.46 |
| MACD | -0.12 | -0.17 |
| Stochastic Oscillator | 87.52 | 26.11 |
Price Performance
Historical ComparisonAbout ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About ASM Avino Silver & Gold Mines Ltd. (Canada)
Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.